Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

United Labs to Spend $150 Million on China Insulin Business

publication date: Jan 13, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
United Laboratories International will invest 1 billion RMB ($150 million) to gain a foothold in China’s insulin market. Last week, the company announced it received SFDA approval for three insulin products, bringing its total to five. The company hopes to gain a 10% share of China’s insulin market within three years. More details....

Stock Symbol: (HK: 3933)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...